Opto Circuits India Limited
http://www.optoindia.com/
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Latest From Opto Circuits India Limited
Teva Starts The Year With Phase III Data And Growth
Teva reported positive Phase III data for a long-acting version of olanzapine for schizophrenia, coinciding with its first quarter sales and earnings release.
Deal Watch: AbbVie Teams With MedinCell On Long-Acting Injectables
Collaboration Edition: Including deals involving Evotec/Variant, Sanofi/IGM/Nurix, ABVC/OncoX and Harmony/Bioprojet, along with tech transfer agreements and deals in brief.
Teva Expects To Carve Out Sizable Niche For Uzedy In Antipsychotic Market
Uzedy was recently approved by the US FDA as an extended-release subcutaneous formula of risperidone; it is poised to be a new prong in Teva’s branded portfolio.
Teva Prepares To Launch LAI Risperidone After US Approval
Teva has indicated an imminent launch after gaining a long-awaited FDA approval for the Uzedy long-acting injectable risperidone 505(b)(2) hybrid product on which the firm has partnered with MedinCell. Pricing information has also been revealed.
Company Information
- Industry
- Medical Devices
-
Medical Devices
- Consumables, Central Supplies
- Implantable Devices
- Infusion Therapy Equipment and Supplies
- Monitoring Equipment & Devices
- Surgical Equipment & Devices
-
Surgical Equipment & Devices
- Minimally or Less Invasive
-
In Vitro Diagnostics
- Biosensors
- Other Names / Subsidiaries
-
- Advanced Micronic Devices Ltd.
- Cardiac Science Corporation
- Criticare Systems Inc.
- Devon Innovations Pvt Ltd.
- Eurocor Gmbh
- Maxcor Lifescience Inc.
- Mediaid Inc.
- N.S. Remedies Pvt. Ltd.
- Opto Cardiac Care Ltd.
- Opto Circuits (Malaysia) SDN BHD
- Opto Eurocor Healthcare Ltd.
- Opto Infrastructure Ltd.
- Ormed Medical Technology Ltd.
- Unetixs Vascular Inc.
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Company
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice